{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:39:37Z","timestamp":1793968777881,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Periprosthetic joint infection (PJI) following total joint arthroplasty (TJA) is a serious complication for patients. Some joint surgeons have tried to use vancomycin powder (VP) in total knee and total hip arthroplasty to prevent postoperative PJI, but its effect is still not clear. At present, there is no meta-analysis that specifically analyses the effect of different doses of vancomycin powder on the incidence of PJI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We carried out a search based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and identified the studies we needed. Review Manager (RevMan) 5.3 software was employed for statistical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The analysis of primary TKA (PTKA) showed that using 1\u00a0g (RR\u20090.38, 95% CI\u20090.22\u20130.67 [<jats:italic>P<\/jats:italic>\u2009=\u20090.0008]) and 2\u00a0g (RR\u20090.48, 95% CI\u20090.31\u20130.74 [<jats:italic>P<\/jats:italic>\u2009=\u20090.0008]) of vancomycin powder in primary TKA (PTKA) could all significantly prevent PJI. The analysis of primary THA (PTHA) showed that using 1\u00a0g (RR\u20090.37, 95% CI\u20090.17\u20130.80 [<jats:italic>P<\/jats:italic>\u2009=\u20090.01]) of vancomycin powder effectively decreased the incidence of PJI, while using 2\u00a0g (RR\u20091.02, 95% CI\u20090.53\u20131.97 [<jats:italic>P<\/jats:italic>\u2009=\u20090.94]) of vancomycin powder had no significant effect on preventing PJI. Because the data were abnormal, we believed the conclusion that using 2\u00a0g of vancomycin powder in primary THA had no effect on preventing PJI was doubtful. Using vancomycin powder in revision TKA (RTKA) significantly reduced the PJI rate (RR\u20090.33, 95% CI\u20090.14\u20130.77 [<jats:italic>P<\/jats:italic>\u2009=\u20090.01]), similar to revision THA (RTHA) (RR\u20090.37, 95% CI\u20090.14\u20130.96 [<jats:italic>P<\/jats:italic>\u2009=\u20090.04]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In primary TKA, both 1\u00a0g and 2\u00a0g of vancomycin powder can effectively prevent PJI. In primary THA, using 1\u00a0g of vancomycin powder is a better choice, while the effect of using 2\u00a0g of vancomycin powder is not clear, and a more prospective randomized controlled trial should be done to verify it. In revision TKA and revision THA, vancomycin powder is a good choice to prevent PJI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-022-03445-2","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:27:57Z","timestamp":1671251277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of different doses of vancomycin powder in total knee and hip arthroplasty on the periprosthetic joint infection rate: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Shiyu","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhize","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-guo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"issue":"1","key":"3445_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169068","volume":"12","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Beswick AD, Peters TJ, et al. Health care needs and support for patients undergoing treatment for prosthetic joint infection following hip or knee arthroplasty: a systematic review. PLoS ONE. 2017;12(1): e0169068.","journal-title":"PLoS ONE"},{"issue":"10016","key":"3445_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0140-6736(14)61798-0","volume":"387","author":"BH Kapadia","year":"2016","unstructured":"Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection. Lancet. 2016;387(10016):386\u201394.","journal-title":"Lancet"},{"key":"3445_CR3","first-page":"51","volume":"64","author":"J Parvizi","year":"2015","unstructured":"Parvizi J, Heller S, Berend KR, Della Valle CJ, Springer BD. Periprosthetic joint infection: the algorithmic approach and emerging evidence. Instr Course Lect. 2015;64:51\u201360.","journal-title":"Instr Course Lect"},{"issue":"2","key":"3445_CR4","first-page":"72","volume":"3","author":"A Shahi","year":"2015","unstructured":"Shahi A, Parvizi J. Prevention of periprosthetic joint infection. Arch Bone Jt Surg. 2015;3(2):72\u201381.","journal-title":"Arch Bone Jt Surg"},{"issue":"3","key":"3445_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3109\/17453674.2015.1011983","volume":"86","author":"PH Gundtoft","year":"2015","unstructured":"Gundtoft PH, Overgaard S, Sch\u00f8nheyder HC, M\u00f8ller JK, Kj\u00e6rsgaard-Andersen P, Pedersen AB. The \u201ctrue\u201d incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop. 2015;86(3):326\u201334.","journal-title":"Acta Orthop"},{"issue":"3","key":"3445_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/17453674.2015.1035173","volume":"86","author":"K Huotari","year":"2015","unstructured":"Huotari K, Peltola M, J\u00e4msen E. The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop. 2015;86(3):321\u20135.","journal-title":"Acta Orthop"},{"issue":"1","key":"3445_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11999-009-1013-5","volume":"468","author":"SM Kurtz","year":"2010","unstructured":"Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010;468(1):52\u20136.","journal-title":"Clin Orthop Relat Res"},{"key":"3445_CR8","doi-asserted-by":"crossref","unstructured":"Levine DPJCid. Vancomycin: a history. 2006;42(Supplement_1):S5-S12.","DOI":"10.1086\/491709"},{"issue":"7","key":"3445_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.otsr.2014.05.022","volume":"100","author":"L Xiong","year":"2014","unstructured":"Xiong L, Pan Q, Jin G, Xu Y, Hirche C. Topical intrawound application of vancomycin powder in addition to intravenous administration of antibiotics: a meta-analysis on the deep infection after spinal surgeries. Orthop Traumatol Surg Res. 2014;100(7):785\u20139.","journal-title":"Orthop Traumatol Surg Res"},{"issue":"5","key":"3445_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.wneu.2014.12.033","volume":"83","author":"J Bakhsheshian","year":"2015","unstructured":"Bakhsheshian J, Dahdaleh NS, Lam SK, Savage JW, Smith ZA. The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence. World Neurosurg. 2015;83(5):816\u201323.","journal-title":"World Neurosurg"},{"issue":"3","key":"3445_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.otsr.2020.01.007","volume":"106","author":"X Xu","year":"2020","unstructured":"Xu X, Zhang X, Zhang Y, Chen C, Yu H, Xue E. Role of intra-wound powdered vancomycin in primary total knee arthroplasty. Orthop Traumatol Surg Res. 2020;106(3):417\u201320.","journal-title":"Orthop Traumatol Surg Res"},{"key":"3445_CR12","first-page":"284","volume":"30","author":"JE Otte","year":"2017","unstructured":"Otte JE, Politi JR, Chambers B, Smith CA. Intrawound vancomycin powder reduces early prosthetic joint infections in revision hip and knee arthroplasty. Surg Technol Int. 2017;30:284\u20139.","journal-title":"Surg Technol Int"},{"issue":"4","key":"3445_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.artd.2018.07.011","volume":"4","author":"NN Patel","year":"2018","unstructured":"Patel NN, Guild GN 3rd, Kumar AR. Intrawound vancomycin in primary hip and knee arthroplasty: a safe and cost-effective means to decrease early periprosthetic joint infection. Arthroplast Today. 2018;4(4):479\u201383.","journal-title":"Arthroplast Today"},{"issue":"1","key":"3445_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13018-021-02344-2","volume":"16","author":"MN Tahmasebi","year":"2021","unstructured":"Tahmasebi MN, Vaziri AS, Vosoughi F, Tahami M, Khalilizad M, Rabie H. Low post-arthroplasty infection rate is possible in developing countries: long-term experience of local vancomycin use in Iran. J Orthop Surg Res. 2021;16(1):199.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"3445_CR15","doi-asserted-by":"publisher","first-page":"13053","DOI":"10.1038\/s41598-020-69958-0","volume":"10","author":"G Matziolis","year":"2020","unstructured":"Matziolis G, Brodt S, B\u00f6hle S, Kirschberg J, Jacob B, R\u00f6hner E. Intraarticular vancomycin powder is effective in preventing infections following total hip and knee arthroplasty. Sci Rep. 2020;10(1):13053.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"3445_CR16","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.jcot.2017.08.007","volume":"9","author":"C Winkler","year":"2018","unstructured":"Winkler C, Dennison J, Wooldridge A, et al. Do local antibiotics reduce periprosthetic joint infections? A retrospective review of 744 cases. J Clin Orthop Trauma. 2018;9(Suppl 1):S34\u20139.","journal-title":"J Clin Orthop Trauma"},{"issue":"7s","key":"3445_CR17","doi-asserted-by":"publisher","first-page":"S314","DOI":"10.1016\/j.arth.2020.12.036","volume":"36","author":"DB Buchalter","year":"2021","unstructured":"Buchalter DB, Teo GM, Kirby DJ, Schwarzkopf R, Aggarwal VK, Long WJ. Does the organism profile of periprosthetic joint infections change with a topical vancomycin powder and dilute povidone-iodine lavage protocol? J Arthroplasty. 2021;36(7s):S314\u20139.","journal-title":"J Arthroplasty"},{"issue":"3","key":"3445_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.arth.2017.10.044","volume":"33","author":"AM Riesgo","year":"2018","unstructured":"Riesgo AM, Park BK, Herrero CP, Yu S, Schwarzkopf R, Iorio R. Vancomycin povidone-iodine protocol improves survivorship of periprosthetic joint infection treated with irrigation and debridement. J Arthroplasty. 2018;33(3):847\u201350.","journal-title":"J Arthroplasty"},{"issue":"1","key":"3445_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5371\/hp.2018.30.1.37","volume":"30","author":"BL Dial","year":"2018","unstructured":"Dial BL, Lampley AJ, Green CL, Hallows R. Intrawound vancomycin powder in primary total hip arthroplasty increases rate of sterile wound complications. Hip Pelvis. 2018;30(1):37\u201344.","journal-title":"Hip Pelvis"},{"issue":"5","key":"3445_CR20","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.3928\/01477447-20190321-05","volume":"42","author":"EM Cohen","year":"2019","unstructured":"Cohen EM, Marcaccio S, Goodman AD, Lemme NJ, Limbird R. Efficacy and cost-effectiveness of topical vancomycin powder in primary cementless total hip arthroplasty. Orthopedics. 2019;42(5):e430\u20136.","journal-title":"Orthopedics"},{"issue":"2","key":"3445_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jajs.2017.08.001","volume":"4","author":"K Khatri","year":"2017","unstructured":"Khatri K, Bansal D, Singla R, Sri S. Prophylactic intrawound application of vancomycin in total knee arthroplasty. J Arthros Joint Surg. 2017;4(2):61\u20134.","journal-title":"J Arthros Joint Surg"},{"issue":"7","key":"3445_CR22","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1007\/s00167-019-05498-z","volume":"27","author":"M Hanada","year":"2019","unstructured":"Hanada M, Nishikino S, Hotta K, Furuhashi H, Hoshino H, Matsuyama Y. Intrawound vancomycin powder increases post-operative wound complications and does not decrease periprosthetic joint infection in primary total and unicompartmental knee arthroplasties. Knee Surg Sports Traumatol Arthrosc. 2019;27(7):2322\u20137.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"9","key":"3445_CR23","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1007\/s00167-019-05778-8","volume":"28","author":"IA Yavuz","year":"2020","unstructured":"Yavuz IA, Oken OF, Yildirim AO, Inci F, Ceyhan E, Gurhan U. No effect of vancomycin powder to prevent infection in primary total knee arthroplasty: a retrospective review of 976 cases. Knee Surg Sports Traumatol Arthrosc. 2020;28(9):3055\u201360.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"5","key":"3445_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/microorganisms8050671","volume":"8","author":"AA Koutalos","year":"2020","unstructured":"Koutalos AA, Drakos A, Fyllos A, Doxariotis N, Varitimidis S, Malizos KN. Does intra-wound vancomycin powder affect the action of intra-articular tranexamic acid in total joint replacement? Microorganisms. 2020;8(5):671.","journal-title":"Microorganisms."},{"key":"3445_CR25","unstructured":"Shiyu L, Zhize Y, Liu J. The effect of different dosage of intrawound vancomycin powder on Periprosthetic joint infection (PJI) in total knee and total hip arthroplasty: a systematic review and meta-analysis. 2021."},{"key":"3445_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"3445_CR27","unstructured":"GA W. Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2008(5)."},{"issue":"7414","key":"3445_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"11","key":"3445_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"1","key":"3445_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.22603\/ssrr.2016-0002","volume":"2","author":"H Takahashi","year":"2018","unstructured":"Takahashi H, Iida Y, Yokoyama Y, et al. Use of intrawound vancomycin powder against postoperative infection after spine surgery. Spine Surg Relat Res. 2018;2(1):18\u201322.","journal-title":"Spine Surg Relat Res"},{"issue":"10","key":"3445_CR31","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.spinee.2013.06.030","volume":"13","author":"WO Shaffer","year":"2013","unstructured":"Shaffer WO, Baisden JL, Fernand R, Matz PG. An evidence-based clinical guideline for antibiotic prophylaxis in spine surgery. Spine J. 2013;13(10):1387\u201392.","journal-title":"Spine J"},{"issue":"6","key":"3445_CR32","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3171\/2014.8.SPINE1445","volume":"21","author":"NR Khan","year":"2014","unstructured":"Khan NR, Thompson CJ, DeCuypere M, et al. A meta-analysis of spinal surgical site infection and vancomycin powder. J Neurosurg Spine. 2014;21(6):974\u201383.","journal-title":"J Neurosurg Spine"},{"issue":"11","key":"3445_CR33","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1086\/379321","volume":"37","author":"M Melzer","year":"2003","unstructured":"Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis. 2003;37(11):1453\u201360.","journal-title":"Clin Infect Dis"},{"issue":"15","key":"3445_CR34","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","volume":"298","author":"RM Klevens","year":"2007","unstructured":"Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763\u201371.","journal-title":"JAMA"},{"issue":"9","key":"3445_CR35","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1086\/522186","volume":"45","author":"GA Noskin","year":"2007","unstructured":"Noskin GA, Rubin RJ, Schentag JJ, et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998\u20132003). Clin Infect Dis. 2007;45(9):1132\u201340.","journal-title":"Clin Infect Dis"},{"issue":"24","key":"3445_CR36","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1097\/BRS.0b013e3181ff2cb1","volume":"36","author":"FA Sweet","year":"2011","unstructured":"Sweet FA, Roh M, Sliva C. Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine (Phila Pa 1976). 2011;36(24):2084\u20138.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"6","key":"3445_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2106\/JBJS.K.00756","volume":"95","author":"JM Pahys","year":"2013","unstructured":"Pahys JM, Pahys JR, Cho SK, et al. Methods to decrease postoperative infections following posterior cervical spine surgery. J Bone Joint Surg Am. 2013;95(6):549\u201354.","journal-title":"J Bone Joint Surg Am"},{"issue":"22","key":"3445_CR38","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1097\/BRS.0000000000000533","volume":"39","author":"AA Theologis","year":"2014","unstructured":"Theologis AA, Demirkiran G, Callahan M, Pekmezci M, Ames C, Deviren V. Local intrawound vancomycin powder decreases the risk of surgical site infections in complex adult deformity reconstruction: a cost analysis. Spine (Phila Pa 1976). 2014;39(22):1875\u201380.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"8","key":"3445_CR39","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.arth.2019.03.071","volume":"34","author":"ND Heckmann","year":"2019","unstructured":"Heckmann ND, Mayfield CK, Culvern CN, Oakes DA, Lieberman JR, Della Valle CJ. Systematic review and meta-analysis of intrawound vancomycin in total hip and total knee arthroplasty: a call for a prospective randomized trial. J Arthroplasty. 2019;34(8):1815\u201322.","journal-title":"J Arthroplasty"},{"issue":"4","key":"3445_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.otsr.2020.09.006","volume":"107","author":"Z Peng","year":"2021","unstructured":"Peng Z, Lin X, Kuang X, Teng Z, Lu S. The application of topical vancomycin powder for the prevention of surgical site infections in primary total hip and knee arthroplasty: A meta-analysis. Orthop Traumatol Surg Res. 2021;107(4): 102741.","journal-title":"Orthop Traumatol Surg Res"},{"issue":"11","key":"3445_CR41","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1302\/2046-3758.911.BJR-2020-0190.R2","volume":"9","author":"H Xu","year":"2020","unstructured":"Xu H, Yang J, Xie J, et al. Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty. Bone Joint Res. 2020;9(11):778\u201388.","journal-title":"Bone Joint Res"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-022-03445-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:30:01Z","timestamp":1671251401000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-022-03445-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3445"],"URL":"https:\/\/doi.org\/10.1186\/s13018-022-03445-2","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a meta-analysis and therefore no ethics committee and informed consents are required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"546"}}